Author:
Schottelius Margret,Šimeček Jakub,Hoffmann Frauke,Willibald Marina,Schwaiger Markus,Wester Hans-Jürgen
Publisher
Springer Science and Business Media LLC
Subject
Radiology, Nuclear Medicine and imaging
Reference21 articles.
1. Mojtahedi A, Thamake S, Tworowska I, Ranganathan D, Delpassand ES: The value of (68)Ga-DOTATATE PET/CT in diagnosis and management of neuroendocrine tumors compared to current FDA approved imaging modalities: a review of literature. Am J Nucl Med Mol Imaging. 2014, 4: 426–34.
2. Banerjee SR, Pomper MG: Clinical applications of gallium-68. Appl Radiat Isotopes. 2013, 76: 2–13. 10.1016/j.apradiso.2013.01.039
3. Velikyan I, Sundin A, Sorensen J, Lubberink M, Sandstrom M, Garske-Roman U, et al.: Quantitative and qualitative intrapatient comparison of Ga-68-DOTATOC and Ga-68-DOTATATE: net uptake rate for accurate quantification. J Nucl Med. 2014, 55: 204–10. 10.2967/jnumed.113.126177
4. Antunes P, Ginj M, Zhang H, Waser B, Baum RP, Reubi JC, et al.: Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals? Eur J Nucl Med Mol I. 2007, 34: 982–93. 10.1007/s00259-006-0317-x
5. Wild D, Bomanji JB, Benkert P, Maecke H, Ell PJ, Reubi JC, et al.: Comparison of Ga-68-DOTANOC and Ga-68-DOTATATE PET/CT within patients with gastroenteropancreatic neuroendocrine tumors. J Nucl Med. 2013, 54: 364–72. 10.2967/jnumed.112.111724
Cited by
50 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献